✦ LIBER ✦

Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease

✍ Scribed by Salloway, Stephen; Sperling, Reisa; Fox, Nick C.; Blennow, Kaj; Klunk, William; Raskind, Murray; Sabbagh, Marwan; Honig, Lawrence S.; Porsteinsson, Anton P.; Ferris, Steven; Reichert, Marcel; Ketter, Nzeera; Nejadnik, Bijan; Guenzler, Volkmar; Miloslavsky, Maja; Wang, Daniel; Lu, Yuan; Lull, Julia; Tudor, Iulia Cristina; Liu, Enchi; Grundman, Michael; Yuen, Eric; Black, Ronald; Brashear, H. Robert

Book ID: 121471850
Publisher: Massachusetts Medical Society
Year: 2014
Tongue: English
Weight: 620 KB
Volume: 370
Category: Article
ISSN: 0096-6762
DOI: 10.1056/NEJMoa1304839

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase 3 Trials of Solanezumab for Mild-t

Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease

✍ Doody, Rachelle S.; Thomas, Ronald G.; Farlow, Martin; Iwatsubo, Takeshi; Vellas 📂 Article 📅 2014 🏛 Massachusetts Medical Society 🌐 English ⚖ 514 KB

O3-04-05: Clinical trials of bapineuzuma

O3-04-05: Clinical trials of bapineuzumab, a beta-amyloid-targeted immunotherapy in patients with mild to moderate Alzheimer's disease

✍ Michael Grundman; Ronald Black 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Correlation of brain atrophy with clinic

Correlation of brain atrophy with clinical progression in mild-to-moderate Alzheimer's disease: Results from the volumetric MRI substudies of two phase III trials with bapineuzumab

✍ Novak, Gerald; Einstein, Steven; Lu, Yuan; Tudor, Iulia Cristina; Gregg, Keith; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Pharmacokinetics and pharmacodynamics of

Pharmacokinetics and pharmacodynamics of bapineuzumab following multiple intravenous infusions in patients with mild-to-moderate Alzheimer's disease

✍ Raskind, Murray; Liang, Earvin; Sperling, Reisa; Boxer, Adam; Ross, Joel; Brody, 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Effect of bapineuzumab on CSF p-tau and

Effect of bapineuzumab on CSF p-tau and t-tau in mild-to-moderate Alzheimer's disease: Results from two phase III trials in APOE-ε4 carriers and noncarriers

✍ Streffer, Johannes; Blennow, Kaj; Salloway, Stephen; Zetterberg, Henrik; Xu, Yi- 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Safety, tolerability and pharmacokinetic

Safety, tolerability and pharmacokinetics of single-ascending doses of bapineuzumab in Japanese patients with mild-to-moderate Alzheimer's disease

✍ Arai, Heii; Umemura, Kazao; Ichimiya, Yosuke; Iseki, Eizo; Eto, Ko; Shibata, Nob 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 174 KB